|
MCCC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.92919951919657E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.31829999641775E-08 |
| Normal-vs-Stage2 |
1.418190E-02 |
| Normal-vs-Stage3 |
3.8931002865894E-10 |
| Normal-vs-Stage4 |
6.11049999488245E-08 |
| Stage1-vs-Stage2 |
6.635900E-02 |
| Stage1-vs-Stage3 |
5.346400E-02 |
| Stage1-vs-Stage4 |
1.095560E-01 |
| Stage2-vs-Stage3 |
8.355400E-03 |
| Stage2-vs-Stage4 |
1.124150E-02 |
| Stage3-vs-Stage4 |
8.894200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.19589943187771E-11 |
| Normal-vs-AfricanAmerican |
2.12370000000073E-05 |
| Normal-vs-Asian |
1.954450E-04 |
| Caucasian-vs-AfricanAmerican |
4.825600E-01 |
| Caucasian-vs-Asian |
3.003600E-01 |
| AfricanAmerican-vs-Asian |
2.127800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.35029999906544E-08 |
| Normal-vs-Female |
4.37559999344472E-09 |
| Male-vs-Female |
6.676800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.11209999489981E-08 |
| Normal-vs-Age(41-60Yrs) |
1.72250000041174E-07 |
| Normal-vs-Age(61-80Yrs) |
1.98529999995145E-07 |
| Normal-vs-Age(81-100Yrs) |
2.387900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.820200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.626200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.555600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.917600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.181410E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.130760E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.059500E-02 |
| Classical-VS-Follicular |
1.978030E-02 |
| Classical-VS-Other |
6.576600E-01 |
| Classical-VS-Normal |
1.13119957845242E-10 |
| Tall-VS-Follicular |
5.614000E-04 |
| Tall-VS-Other |
1.416210E-01 |
| Tall-VS-Normal |
8.13849998504423E-09 |
| Follicular-VS-Other |
6.820600E-01 |
| Follicular-VS-Normal |
5.862100E-03 |
| Other-VS-Normal |
6.405600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.4558999994474E-07 |
| Normal-vs-N1 |
1.25349997048829E-09 |
| N0-vs-N1 |
2.180200E-02 |
|
|
